HEADER HYDROLASE 07-DEC-07 3BKV TITLE X-RAY STRUCTURE OF THE BACTERIOPHAGE PHIKZ LYTIC TRANSGLYCOSYLASE, TITLE 2 GP144, IN COMPLEX WITH CHITOTETRAOSE, (NAG)4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYTIC TRANSGLYCOSYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHIKZ144; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: IN COMPLEX WITH CHITOTETRAOSE, NAG4 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS PHAGE PHIKZ; SOURCE 3 ORGANISM_TAXID: 169683; SOURCE 4 GENE: ORF144; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PQE 30; SOURCE 9 OTHER_DETAILS: QIAGEN KEYWDS BACTERIOPHAGE, PHIKZ, GP144, TRANSGLYCOSYLASE, PEPTIDOGLYCAN, CELL KEYWDS 2 WALL DEGRADATION, LYSOZYME, TRANSFERASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.FOKINE,K.A.MIROSHNIKOV,M.M.SHNEIDER,V.V.MESYANZHINOV,M.G.ROSSMANN REVDAT 7 15-NOV-23 3BKV 1 REMARK REVDAT 6 30-AUG-23 3BKV 1 HETSYN REVDAT 5 29-JUL-20 3BKV 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 3BKV 1 VERSN REVDAT 3 24-FEB-09 3BKV 1 VERSN REVDAT 2 22-JUL-08 3BKV 1 JRNL REVDAT 1 08-JAN-08 3BKV 0 JRNL AUTH A.FOKINE,K.A.MIROSHNIKOV,M.M.SHNEIDER,V.V.MESYANZHINOV, JRNL AUTH 2 M.G.ROSSMANN JRNL TITL STRUCTURE OF THE BACTERIOPHAGE PHI KZ LYTIC TRANSGLYCOSYLASE JRNL TITL 2 GP144. JRNL REF J.BIOL.CHEM. V. 283 7242 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18160394 JRNL DOI 10.1074/JBC.M709398200 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1036457.470 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 12279 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1262 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1829 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 198 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2095 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 10 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.99000 REMARK 3 B22 (A**2) : -1.99000 REMARK 3 B33 (A**2) : 3.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 51.81 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FLAT BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3BKV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12279 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 8.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 45.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.25500 REMARK 200 FOR SHELL : 14.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.2 REMARK 200 STARTING MODEL: STRUCTURE OF THE PHIKZ GP144 (PDB CODE 3BKH) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2% (V/V) POLYETHYLENE GLYCOL 400, 60 REMARK 280 MM HEPES SODIUM, PH 7.5. PRESENCE OF DTT (5MM) IN THE PROTEIN REMARK 280 SOLUTION WAS IMPORTANT FOR CRYSTALLIZATION, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.88100 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 121.76200 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 91.32150 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 152.20250 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 30.44050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 52 101.51 -55.44 REMARK 500 ALA A 83 143.05 -177.63 REMARK 500 SER A 116 13.08 -148.98 REMARK 500 SER A 127 -156.01 -161.87 REMARK 500 ALA A 129 119.19 -20.28 REMARK 500 GLN A 134 54.84 38.69 REMARK 500 ASP A 156 66.67 -159.02 REMARK 500 LYS A 188 47.69 -70.00 REMARK 500 LEU A 211 0.36 -65.02 REMARK 500 PHE A 223 56.06 -143.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BKH RELATED DB: PDB REMARK 900 STRUCTURE OF THE BACTERIOPHAGE PHIKZ LYTIC TRANSGLYCOSYLASE DBREF 3BKV A 1 260 UNP Q8SD18 Q8SD18_9CAUD 1 260 SEQADV 3BKV HIS A -7 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV HIS A -6 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV HIS A -5 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV HIS A -4 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV HIS A -3 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV GLY A -2 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV SER A -1 UNP Q8SD18 EXPRESSION TAG SEQADV 3BKV ILE A 0 UNP Q8SD18 EXPRESSION TAG SEQRES 1 A 268 HIS HIS HIS HIS HIS GLY SER ILE MSE LYS VAL LEU ARG SEQRES 2 A 268 LYS GLY ASP ARG GLY ASP GLU VAL CYS GLN LEU GLN THR SEQRES 3 A 268 LEU LEU ASN LEU CYS GLY TYR ASP VAL GLY LYS PRO ASP SEQRES 4 A 268 GLY ILE PHE GLY ASN ASN THR PHE ASN GLN VAL VAL LYS SEQRES 5 A 268 PHE GLN LYS ASP ASN CYS LEU ASP SER ASP GLY ILE VAL SEQRES 6 A 268 GLY LYS ASN THR TRP ALA GLU LEU PHE SER LYS TYR SER SEQRES 7 A 268 PRO PRO ILE PRO TYR LYS THR ILE PRO MSE PRO THR ALA SEQRES 8 A 268 ASN LYS SER ARG ALA ALA ALA THR PRO VAL MSE ASN ALA SEQRES 9 A 268 VAL GLU ASN ALA THR GLY VAL ARG SER GLN LEU LEU LEU SEQRES 10 A 268 THR PHE ALA SER ILE GLU SER ALA PHE ASP TYR GLU ILE SEQRES 11 A 268 LYS ALA LYS THR SER SER ALA THR GLY TRP PHE GLN PHE SEQRES 12 A 268 LEU THR GLY THR TRP LYS THR MSE ILE GLU ASN TYR GLY SEQRES 13 A 268 MSE LYS TYR GLY VAL LEU THR ASP PRO THR GLY ALA LEU SEQRES 14 A 268 ARG LYS ASP PRO ARG ILE SER ALA LEU MSE GLY ALA GLU SEQRES 15 A 268 LEU ILE LYS GLU ASN MSE ASN ILE LEU ARG PRO VAL LEU SEQRES 16 A 268 LYS ARG GLU PRO THR ASP THR ASP LEU TYR LEU ALA HIS SEQRES 17 A 268 PHE PHE GLY PRO GLY ALA ALA ARG ARG PHE LEU THR THR SEQRES 18 A 268 GLY GLN ASN GLU LEU ALA ALA THR HIS PHE PRO LYS GLU SEQRES 19 A 268 ALA GLN ALA ASN PRO SER ILE PHE TYR ASN LYS ASP GLY SEQRES 20 A 268 SER PRO LYS THR ILE GLN GLU VAL TYR ASN LEU MSE ASP SEQRES 21 A 268 GLY LYS VAL ALA ALA HIS ARG LYS MODRES 3BKV MSE A 1 MET SELENOMETHIONINE MODRES 3BKV MSE A 80 MET SELENOMETHIONINE MODRES 3BKV MSE A 94 MET SELENOMETHIONINE MODRES 3BKV MSE A 143 MET SELENOMETHIONINE MODRES 3BKV MSE A 149 MET SELENOMETHIONINE MODRES 3BKV MSE A 171 MET SELENOMETHIONINE MODRES 3BKV MSE A 180 MET SELENOMETHIONINE MODRES 3BKV MSE A 251 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 80 8 HET MSE A 94 8 HET MSE A 143 8 HET MSE A 149 8 HET MSE A 171 8 HET MSE A 180 8 HET MSE A 251 8 HET NAG B 1 15 HET NAG B 2 14 HET NAG B 3 14 HET NAG B 4 14 HET NI A 601 1 HET SO4 A 602 5 HETNAM MSE SELENOMETHIONINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NI NICKEL (II) ION HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 3 NI NI 2+ FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *10(H2 O) HELIX 1 1 HIS A -7 MSE A 1 1 9 HELIX 2 2 GLY A 10 CYS A 23 1 14 HELIX 3 3 GLY A 35 ASN A 49 1 15 HELIX 4 4 GLY A 58 TYR A 69 1 12 HELIX 5 5 PRO A 74 ILE A 78 5 5 HELIX 6 6 SER A 86 GLY A 102 1 17 HELIX 7 7 ARG A 104 ALA A 117 1 14 HELIX 8 8 LEU A 136 GLY A 148 1 13 HELIX 9 9 MSE A 149 GLY A 152 5 4 HELIX 10 10 GLY A 159 LYS A 163 5 5 HELIX 11 11 ASP A 164 LEU A 187 1 24 HELIX 12 12 THR A 192 GLY A 203 1 12 HELIX 13 13 GLY A 203 LEU A 211 1 9 HELIX 14 14 LEU A 218 PHE A 223 1 6 HELIX 15 15 PHE A 223 ASN A 230 1 8 HELIX 16 16 ASN A 230 TYR A 235 1 6 HELIX 17 17 THR A 243 ALA A 257 1 15 LINK C ILE A 0 N MSE A 1 1555 1555 1.32 LINK C MSE A 1 N LYS A 2 1555 1555 1.33 LINK C PRO A 79 N MSE A 80 1555 1555 1.34 LINK C MSE A 80 N PRO A 81 1555 1555 1.34 LINK C VAL A 93 N MSE A 94 1555 1555 1.33 LINK C MSE A 94 N ASN A 95 1555 1555 1.33 LINK C THR A 142 N MSE A 143 1555 1555 1.32 LINK C MSE A 143 N ILE A 144 1555 1555 1.33 LINK C GLY A 148 N MSE A 149 1555 1555 1.33 LINK C MSE A 149 N LYS A 150 1555 1555 1.33 LINK C LEU A 170 N MSE A 171 1555 1555 1.32 LINK C MSE A 171 N GLY A 172 1555 1555 1.33 LINK C ASN A 179 N MSE A 180 1555 1555 1.33 LINK C MSE A 180 N ASN A 181 1555 1555 1.33 LINK C LEU A 250 N MSE A 251 1555 1555 1.33 LINK C MSE A 251 N ASP A 252 1555 1555 1.34 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.38 LINK O4 NAG B 2 C1 NAG B 3 1555 1555 1.38 LINK O4 NAG B 3 C1 NAG B 4 1555 1555 1.38 CRYST1 62.322 62.322 182.643 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016046 0.009264 0.000000 0.00000 SCALE2 0.000000 0.018528 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005475 0.00000